The prevalence of hepatitis C in different countries of the ERA/EDTA area

H Köhler¹

Affiliations

H Köhler. Nephrol Dial Transplant. 1995.

. 1995;10(4):468-9.

doi: 10.1093/ndt/10.4.468.

H Köhler¹

No abstract available

Similar articles

Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.
Papatheodoridis GV, Delladetsima I, Koutelou M, Katsoulidou A, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. J Hepatol. 1994 Jun;20(6):843. doi: 10.1016/s0168-8278(05)80160-6. J Hepatol. 1994. PMID: 7523484 No abstract available.
Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
Elzouki AN, Bushala M, Tobji RS, Khfaifi M. Elzouki AN, et al. Nephrol Dial Transplant. 1995;10(4):475-6. doi: 10.1093/ndt/10.4.475. Nephrol Dial Transplant. 1995. PMID: 7542751 No abstract available.
Prevalence of hepatitis C virus antibody among Korean adults.
Kim YS, Pai CH, Chi HS, Kim DW, Min YI, Ahn YO. Kim YS, et al. J Korean Med Sci. 1992 Dec;7(4):333-6. doi: 10.3346/jkms.1992.7.4.333. J Korean Med Sci. 1992. PMID: 1284374 Free PMC article.
[Post-transfusional hepatitis].
González A, Esteban JI. González A, et al. Sangre (Barc). 1993 Jun;38(3):193-200. Sangre (Barc). 1993. PMID: 7692610 Review. Spanish. No abstract available.
Epidemiology of hepatitis C virus in Europe.
Degos F. Degos F. FEMS Microbiol Rev. 1994 Jul;14(3):267-71. doi: 10.1111/j.1574-6976.1994.tb00098.x. FEMS Microbiol Rev. 1994. PMID: 7522025 Review.

The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study.
Shamshirsaz AA, Kamgar M, Bekheirnia MR, Ayazi F, Hashemi SR, Bouzari N, Habibzadeh MR, Pourzahedgilani N, Broumand V, Shamshirsaz AH, Moradi M, Borghei M, Haghighi NN, Broumand B. Shamshirsaz AA, et al. BMC Nephrol. 2004 Oct 7;5:13. doi: 10.1186/1471-2369-5-13. BMC Nephrol. 2004. PMID: 15469615 Free PMC article. Clinical Trial.